Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Common Equity (2018 - 2025)

Outset Medical (OM) has disclosed Common Equity for 8 consecutive years, with $127.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 373.37% to $127.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.0 million through Dec 2025, up 373.37% year-over-year, with the annual reading at $127.0 million for FY2025, 373.37% up from the prior year.
  • Common Equity for Q4 2025 was $127.0 million at Outset Medical, down from $142.4 million in the prior quarter.
  • The five-year high for Common Equity was $431.2 million in Q2 2021, with the low at $26.8 million in Q4 2024.
  • Average Common Equity over 5 years is $210.3 million, with a median of $176.5 million recorded in 2023.
  • The sharpest move saw Common Equity tumbled 78.18% in 2024, then surged 373.37% in 2025.
  • Over 5 years, Common Equity stood at $374.1 million in 2021, then plummeted by 34.24% to $246.0 million in 2022, then tumbled by 50.04% to $122.9 million in 2023, then crashed by 78.18% to $26.8 million in 2024, then soared by 373.37% to $127.0 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $127.0 million, $142.4 million, and $154.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.